Community cancer centers are fast becoming sites for biomarker testing and precision medicine. As clinical research becomes a larger part of community cancer center operations, strengthening tissue collection procedures and considering the establishment of biospecimen repositories are critical concerns.

Join us for a live discussion on Thursday, December 17, about key issues in high integrity tissue acquisition facing community cancer programs. Expert panelists will share their perspectives and best practices on how much, when, and from which sites tissue and other biopsy samples should be collected, how the goals and aims of tissue acquisition impact precision patient care, and more.

Speakers:

• Lawrence D. Wagman, MD, Surgical Oncologist, Medical Director, City of Hope National Medical Center 
• Michelle Shiller, DO, AP/CP, MGP, Co-Medical Director of Genetics, Baylor Sammons Cancer Center; Staff Pathologist, Baylor University Medical Center

Register Today

This webcast is part of the 2020-2021 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research. This important work includes a monthly research newsletter, a series of webcasts on research-related topics of interest, blog posts, and additional resources.